Related Experiment Video
Updated: Apr 23, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
[Research progress on protein succination modification in cancer]
1NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Key Laboratory of Neuroregeneration of Ministry of Education, Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Co-innovation Center of Neuroregeneration, Key Laboratory of Neuroregeneration of Nantong University, Nantong 226001, China.
Abstract:
Metabolic dysregulation is a hallmark of cancer. Mutations in genes encoding key enzymes of the tricarboxylic acid (TCA) cycle can result in the accumulation of "oncometabolites". These metabolites play essential roles in tumor initiation, progression, and immune evasion by inhibiting enzymatic activity or driving covalent protein modifications. Accumulation of fumarate due to TCA cycle disruptions or fumarate hydratase (FH) inactivation mutation affects mitochondrial function, DNA repair, protein function, and the tumor microenvironment. As an α,β-unsaturated electrophilic metabolite, fumarate reacts with cysteine residues on susceptible proteins via Michael addition, generating stable S-(2-succinyl)cysteine (2SC) modifications, a post-translational modification process known as protein succination modification. Research has shown that protein succination modification plays a critical role in tumor initiation, progression, and immune evasion, providing new insights for cancer diagnosis and therapy. Future metabolic interventions targeting succination modification could significantly improve cancer therapies. This review offers a comprehensive overview of the role of protein succination modification in tumor metabolism and immune evasion, along with its potential clinical applications.
Insights
Cancer involves metabolic changes, where fumarate accumulation drives tumor growth and immune evasion. Protein succination modification, a key process, offers new therapeutic targets for improved cancer treatment.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Metabolic dysregulation is a key characteristic of cancer.
- Mutations in tricarboxylic acid (TCA) cycle enzymes lead to oncometabolite accumulation.
- Oncometabolites like fumarate impact tumor initiation, progression, and immune evasion.
Purpose of the Study:
- To review the role of protein succination modification in cancer metabolism and immune evasion.
- To explore the clinical applications of targeting protein succination modification.
Main Methods:
- Literature review of studies on fumarate accumulation and protein succination.
- Analysis of the mechanisms by which fumarate affects cellular processes.
- Examination of the link between succination modification and tumor microenvironment.
Main Results:
- Fumarate accumulation, often due to fumarate hydratase (FH) inactivation, alters mitochondrial function, DNA repair, and protein activity.
- Fumarate modifies cysteine residues on proteins, forming S-(2-succinyl)cysteine (2SC) modifications.
- Protein succination modification is implicated in tumor initiation, progression, and immune evasion.
Conclusions:
- Protein succination modification is a critical factor in cancer development and immune evasion.
- Targeting succination modification presents a promising strategy for novel cancer therapies.
- Further research into metabolic interventions for succination modification could enhance cancer treatment outcomes.
More Related Videos
12:11Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
Published on: February 27, 2020
08:12Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
Published on: January 8, 2018
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Abnormal Proliferation